152 related articles for article (PubMed ID: 36642751)
1. Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies.
Roloff GW; Shaw R; O'Connor TE; Hathaway F; Drazer MW
J Genet Couns; 2023 Jun; 32(3):744-749. PubMed ID: 36642751
[TBL] [Abstract][Full Text] [Related]
2. Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies.
Roloff GW; Godley LA; Drazer MW
Genet Med; 2021 Jan; 23(1):211-214. PubMed ID: 32807974
[TBL] [Abstract][Full Text] [Related]
3. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Drazer MW; Kadri S; Sukhanova M; Patil SA; West AH; Feurstein S; Calderon DA; Jones MF; Weipert CM; Daugherty CK; Ceballos-López AA; Raca G; Lingen MW; Li Z; Segal JP; Churpek JE; Godley LA
Blood Adv; 2018 Jan; 2(2):146-150. PubMed ID: 29365323
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
[TBL] [Abstract][Full Text] [Related]
5. Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.
Akpan IJ; Osman AEG; Drazer MW; Godley LA
Curr Hematol Malig Rep; 2018 Dec; 13(6):426-434. PubMed ID: 30259338
[TBL] [Abstract][Full Text] [Related]
6. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
7. Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes.
Hamidi A; Roloff GW; Shaw R; Acevedo M; Smith S; Drazer MW
Leuk Lymphoma; 2023 Sep; 64(9):1562-1565. PubMed ID: 37294121
[TBL] [Abstract][Full Text] [Related]
8. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
9. Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy.
O'Connor TE; Shaw R; Madero-Marroquin R; Roloff GW
Front Oncol; 2023; 13():1180439. PubMed ID: 37251919
[TBL] [Abstract][Full Text] [Related]
10. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology.
Roloff GW; Drazer MW; Godley LA
JCO Precis Oncol; 2021 Nov; 5():107-122. PubMed ID: 34994594
[TBL] [Abstract][Full Text] [Related]
11. [Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC].
Coiteux V; Fenwarth L; Duployez N; Ainaoui M; Borel C; Polomeni A; Yakoub-Agha I; Chalandon Y
Bull Cancer; 2023 Feb; 110(2S):S13-S29. PubMed ID: 36307324
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
13. Identifying potential germline variants from sequencing hematopoietic malignancies.
Kraft IL; Godley LA
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):219-227. PubMed ID: 33275754
[TBL] [Abstract][Full Text] [Related]
14. Identifying potential germline variants from sequencing hematopoietic malignancies.
Kraft IL; Godley LA
Blood; 2020 Nov; 136(22):2498-2506. PubMed ID: 33236764
[TBL] [Abstract][Full Text] [Related]
15. Identifying patients with genetic predisposition to acute myeloid leukemia.
Obrochta E; Godley LA
Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
Saygin C; Roloff G; Hahn CN; Chhetri R; Gill S; Elmariah H; Talati C; Nunley E; Gao G; Kim A; Bishop M; Kosuri S; Das S; Singhal D; Venugopal P; Homan CC; Brown A; Scott HS; Hiwase D; Godley LA
Blood Adv; 2023 Feb; 7(4):549-554. PubMed ID: 36001442
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
[TBL] [Abstract][Full Text] [Related]
18. Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
Arai H; Matsui H; Chi S; Utsu Y; Masuda S; Aotsuka N; Minami Y
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203823
[TBL] [Abstract][Full Text] [Related]
19. Germline predisposition to hematopoietic malignancies.
Feurstein S; Drazer M; Godley LA
Hum Mol Genet; 2021 Oct; 30(20):R225-R235. PubMed ID: 34100074
[TBL] [Abstract][Full Text] [Related]
20. Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes.
Ansar S; Malcolmson J; Farncombe KM; Yee K; Kim RH; Sibai H
Genet Med; 2022 Nov; 24(11):2367-2379. PubMed ID: 36112138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
